Bedoradrine Sulfate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBedoradrine Sulfate
Drug Alias Name贝多拉君bedoradrinabedoradrinumKUR-1246MLN-221 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveStatus AsthmaticusAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedicinova IncKissei Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveStatus AsthmaticusAsthma

Other Information

ATC CodeN/A
Related LinksKEGG